He leads a team of consultants, strategists, and data scientists focused on driving healthcare improvement through value demonstration, stakeholder engagement, predictive and applied analytics, and data innovations. His team of experts, extracting knowledge and insights from one of the largest US patient data sources, supports a diverse array of healthcare stakeholders including commercial, HEOR, medical, and public policy professionals at biopharmaceutical companies, device manufacturers, health plans, delivery networks, patient advocacy groups, and medical societies.John’s technical expertise is grounded in HEOR and using evidence-based medicine to achieve commercial aims and long-term strategic planning. He has a strong background in sales and new business development, and regularly advises healthcare executives on maximizing commercial and medical potential within a dynamic and complex healthcare ecosystem. An accomplished public speaker, he presents regularly at conferences, national meetings, and academic environments.Prior to joining Avalere, John served as a health economist at Oxford Outcomes (now part of ICON) and a research associate within the Health Economics practice at United BioSource Corporation (now Evidera).John holds an MPH from The Johns Hopkins Bloomberg School of Public Health, an MBA from The Johns Hopkins Carey Business School, and a BA in biology from the University of Pennsylvania. His research has been published in numerous peer-reviewed journals.
John E. Linnehan leads our Health Economics and Applied Analytics Practice.
Register now to join Avalere experts on January 10, 2019 from 1 – 2 PM EDT as they examine the top healthcare priorities to watch.
Avalere experts examine the challenges and successful approaches to outcomes-based contracts.
Avalere experts say use of outcomes-based contracts could further goals to improve patient outcomes and manage drug costs
Hepatitis C and Oncology Are Top Therapeutic Area Targets